Daily Health & Wellness Brief · September 8th

Storyflo Health — Daily Health Brief · Sep 8, 2026 · 3m

From storyflo. This is your daily audio brief. Hey, it's Chloe. September 8th. Ten stories — one trial, three reviews, six takes you can actually use. Let's get into it. First, from Endpoints Pharma. Novartis sinks after second disastrous trial failure, this time of Avidity-acquired drug. Novartis faced a significant setback after the failure of a drug acquired from Avidity. This marks their second trial failure in a short period, raising concerns about their pipeline and ability to deliver effective treatments. The specific details of the trial results haven't been disclosed, but the…